Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Jun 28;20(13):3177.
doi: 10.3390/ijms20133177.

The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism

Affiliations
Review

The Anti-Cancer Effect of Quercetin: Molecular Implications in Cancer Metabolism

Marjorie Reyes-Farias et al. Int J Mol Sci. .

Abstract

Cancer is a problem with worldwide importance and is the second leading cause of death globally. Cancer cells reprogram their metabolism to support their uncontrolled expansion by increasing biomass (anabolic metabolism-glycolysis) at the expense of their energy (bioenergetics- mitochondrial function) requirements. In this aspect, metabolic reprogramming stands out as a key biological process in understanding the conversion of a normal cell into a neoplastic precursor. Quercetin is the major representative of the flavonoid subclass of flavonols. Quercetin is ubiquitously present in fruits and vegetables, being one of the most common dietary flavonols in the western diet. The anti-cancer effects of quercetin include its ability to promote the loss of cell viability, apoptosis and autophagy through the modulation of PI3K/Akt/mTOR, Wnt/-catenin, and MAPK/ERK1/2 pathways. In this review, we discuss the role of quercetin in cancer metabolism, addressing specifically its ability to target molecular pathways involved in glucose metabolism and mitochondrial function.

Keywords: PI3K/Akt pathway; cancer; glycolysis; mitochondrial function; quercetin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Ferlay J., Colombet M., Soerjomataram I., Mathers C., Parkin D.M., Pineros M., Znaor A., Bray F. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer. 2019;144:1941–1953. doi: 10.1002/ijc.31937. - DOI - PubMed
    1. World Health Organization (WHO) World Cancer Report 2014. International Agency for Research on Cancer; Lyon, France: 2014.
    1. GCO Estimated Number of Incident Cases from 2018 to 2040, all Cancers, Both Sexes, all Ages. [(accessed on 2 May 2019)]; Available online: http://gco.iarc.fr/tomorrow/home.
    1. Bray F., Colombet M., Mery L., Piñeros M., Znaor A., Zanetti R., Ferlay J. CI5 XI: Cancer Incidence in Five Continents. Volume XI International Agency for Research on Cancer; Lyon, France: 2017. Electronic Version.
    1. World Health Organization (WHO) Cancer. [(accessed on 2 May 2019)]; Available online: https://www.who.int/news-room/fact-sheets/detail/cancer.

LinkOut - more resources